Screener
Celldex Therapeutics CLDX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's net margin?
- Celldex Therapeutics (CLDX) reported net margin of -190,220.9% in Q2 2026.
- How has Celldex Therapeutics's net margin changed year-over-year?
- Celldex Therapeutics's net margin decreased by 5418.6% year-over-year, from -3,446.9% to -190,220.9%.
- What is the long-term trend for Celldex Therapeutics's net margin?
- Over 5 years (2020 to 2025), Celldex Therapeutics's net margin has grown at a 83.4% compound annual growth rate (CAGR), from -805.9% to -16,737.2%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Celldex Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude